跳至主要内容
临床试验/NCT03526666
NCT03526666已完成不适用

Collection of Peripheral Blood From Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia for Measuring Baseline Ascorbic Acid Levels and Future Epigenetic Cancer Research

Van Andel Research Institute2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Peripheral blood ascorbic acid levels

研究概览

简要总结

This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.

详细描述

It has previously been established that hematological cancer patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) often exhibit severe vitamin C deficiency from a cohort of patients in Copenhagen. In this study, the investigators aim to determine if those results are conserved in another population/geographical location.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients actively receiving treatment for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML).
  • Patients diagnosed with AML, MDS, or CMML and are treatment naïve.
  • Patients who are 18 years old or older.

排除标准

  • Patients deemed as too ill to participate as determined by the clinical investigator.
  • Non-English speaking patients
  • Patients unable to provide informed consent.

结局指标

主要结局

Peripheral blood ascorbic acid levels

时间窗: 1 year

The level of ascorbic acid

次要结局

  • Evaluation of 5-methylcitosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) levels(1 year)
  • Evaluation of human endogenous retroviral sequences (HERVs) expression(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Jones

Cheif Scientific Officer

Van Andel Research Institute

研究点 (2)

Loading locations...

相似试验